Primary Care: Plasma Cell Dyscrasias: From MGUS to Myeloma 2/16/17
Primary Care: Plasma Cell Dyscrasias: From MGUS to Myeloma 2/16/17
Target Audience
Target Audience: All Primary Care and Interested Providers
Learning Objectives
At the conclusion of this program, clinicians will be better able to:
- Distinguish between MGUS and symptomatic multiple myeloma based on labs, imaging, and symptoms.
- Identify risk factors for MGUS progression to multiple myeloma
- Order the requisite tests and imaging for MGUS and Smoldering Myeloma surveillance.
Additional Information
Kenneth Poon, MD
Oncologist, Kaiser Permanente GSAA & East Bay
The Speaker(s) above and Planner Dr. Arnie Berman have disclosed that they do not have any financial relationships with any commercial interest or any proprietary entity producing health care goods or services that is relevant to this CME program.
The Kaiser Foundation Hospital GSAA is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Foundation Hospital Hayward/Fremont takes responsibility for the content, quality and scientific integrity of this CME activity.
The Kaiser Foundation Hospital San Leandro/Fremont designates this live activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education. Nurses may report 1 credit toward the continuing medical education requirements for license renewal by the California Board of Registered Nurses.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™